XYGF(300159)
Search documents
*ST新研:资本公积金转增股本实施,提示股价除权风险
Xin Lang Cai Jing· 2025-12-22 09:01
*ST新研公告称,本次资本公积金转增股本以现有总股本14.96亿股为基数,按每10股转增12股实施,共 计转增17.95亿股,转增后总股本将增至32.90亿股。股权登记日为2025年12月23日,除权除息日和转增 股本上市日为12月24日。公司拟调整除权参考价格计算公式,若股权登记日收盘价高于转增股本平均价 2.45元/股,次日开盘参考价将调整。公司股票12月23日停牌1天,12月24日复牌。此外,公司提示股价 除权及破产、退市等风险。 ...
*ST新研(300159) - 关于公司股票停牌的提示性公告
2025-12-22 09:00
证券代码:300159 证券简称:*ST 新研 公告编号:2025-077 新疆机械研究院股份有限公司 关于公司股票停牌的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误 导性陈述或重大遗漏。 《新疆机械研究院股份有限公司重整计划》(以下简称"重整计划")已于 2025 年 12 月 16 日由乌鲁木齐中级人民法院裁定批准。根据重整计划,公司因执行 资本公积金转增股本共计转增 1,794,775,108 股股份(最终转增股票准确数量以 中国证券登记结算有限责任公司深圳分公司实际登记确认的数量为准),并拟定 本次资本公积金转增股本的股权登记日为 2025 年 12 月 23 日。 根据《深圳证券交易所创业板股票上市规则》和《深圳证券交易所交易规则》 等有关规定,公司对本次重整计划实施资本公积金转增股本除权参考价格的计算 公式进行了调整,并由申万宏源证券承销保荐有限责任公司为公司调整资本公积 金转增股本除权参考价格的计算公式调整事项出具了专项意见,具体内容详见公 司于 2025 年 12 月 12 日披露的《关于重整计划资本公积金转增股本除权事项的 公告》(公告编号:2025-0 ...
*ST新研(300159) - 关于资本公积金转增股本实施后首个交易日开盘参考价调整事项的第二次风险提示公告
2025-12-22 09:00
证券代码:300159 证券简称:*ST 新研 公告编号:2025-076 新疆机械研究院股份有限公司 关于资本公积金转增股本实施后首个交易日开盘参考价调 整事项的第二次风险提示公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假 记载、误导性陈述或重大遗漏。 特别提示: 由于本次资本公积金转增股本系重整程序中出资人权益调整的一部分,与一 般情形下的上市公司资本公积转增股本存在明显差异,公司根据《深圳证券交易 所交易规则》(2023 年修订)(以下简称《交易规则》)第 4.4.2 条的相关规定, 结合本次重整资本公积金转增股本的实际情况,调整除权参考价格计算公式。如 果股权登记日公司股票收盘价高于本次重整新研股份资本公积金转增股本的平 均价 2.45 元/股,公司股票按照前述拟调整后的除权(息)参考价于股权登记日 次一交易日调整开盘参考价,股权登记日次一交易日证券买卖,按上述开盘参考 价格作为计算涨跌幅度的基准;如果股权登记日公司股票收盘价低于或等于本次 重整新研股份资本公积金转增股本的平均价 2.45 元/股,公司股权登记日次一交 易日的股票开盘参考价无需调整。根据重整计划,结合公司初 ...
12月19日晚间重要公告一览
Xi Niu Cai Jing· 2025-12-19 10:19
Group 1 - Sichuan Chengyu's wholly-owned subsidiary plans to acquire 85% equity of Hubei Jingyi Company for 2.409 billion yuan, enhancing the company's control over highway projects [1] - Huadian Technology signed contracts worth approximately 815 million yuan with Huadian Technology Group for a wind power hydrogen production project [2] - Dongfang Cable and its subsidiary won projects totaling approximately 3.125 billion yuan, accounting for 34.37% of the company's audited revenue for 2024 [3] Group 2 - Heng Rui Medicine received approval for clinical trials of SHR-2906 injection, a self-developed biopharmaceutical aimed at weight control and metabolic regulation [4] - Qingdao Port plans to invest approximately 15.7 billion yuan in two terminal projects [5] - Jingu Co. received a notification to supply low-carbon wheels for two export models to a major domestic car manufacturer, with production expected in 2026 [6] Group 3 - ST Xingguang won a procurement project worth approximately 22.955 million yuan, accounting for 11.96% of the company's revenue for 2024 [7] - Xinbo Co. plans to jointly invest in an alloy materials research institute with partners, focusing on high-performance materials for various industries [8] - Tianqi Lithium's third-phase lithium concentrate expansion project has been completed and is undergoing trial production, with a total capacity of 2.14 million tons per year [9] Group 4 - Changfei Fiber reported that new fiber optic products related to data centers represent a small proportion of total demand [10] - Dongfang Bio's subsidiaries obtained multiple medical device registration certificates, including various testing kits [11] - Xiugang Co. plans to use up to 500 million yuan of idle fundraising for cash management in safe, liquid investment products [12] Group 5 - Jifeng Co. received a project designation for passenger car seat assemblies from a European luxury brand, with a total lifecycle value of approximately 9.8 billion yuan [13] - CanSino initiated Phase I clinical trials for a combined vaccine, completing the first subject enrollment [14] - Dayu Water-saving's subsidiary pre-won a drainage project worth 140 million yuan and another project worth 1 billion yuan [15] Group 6 - Yutong Pharmaceutical's subsidiary received clinical trial approval for YKYY032 injection for treating hyperlipoproteinemia [17] - Diweier announced the departure of a core technical personnel, impacting its technical leadership [18] - Weilang Co.'s controlling shareholder received regulatory measures from the Shandong Securities Regulatory Bureau for failing to fulfill a commitment [19] Group 7 - Xiehe Electronics invested 5 million yuan in a private equity fund focusing on hard technology sectors [20] - Phoenix Optical received a government subsidy of 4.7053 million yuan, representing 35% of its projected net profit for 2024 [21] - China State Construction reported a 0.9% year-on-year increase in new contracts signed in the first 11 months of 2025, totaling 4.0408 trillion yuan [22] Group 8 - Nanguang Energy's pumped storage power station units 1 and 2 have entered trial operation, with units 3 and 4 expected to follow by year-end [23] - Jindalai plans to invest 280 million yuan to acquire a 34% stake in Yunnan Jici Medical Technology [24] - Geer Software terminated its planned acquisition of a majority stake in Weipin Zhiyuan due to failure to reach agreement on key terms [25] Group 9 - Ningbo Fubang completed the absorption merger of its wholly-owned subsidiary, inheriting all assets and liabilities [26] - Zhongyuan Neipei signed a strategic cooperation framework agreement with Ningbo Puzhi Company for humanoid robot-related business [28] - Gongyuan Co. announced a business integration and relocation of its production lines in the East China region [29] Group 10 - Chlor-alkali Chemical's subsidiary plans to invest 2.975 billion yuan in a comprehensive utilization project for waste salt [30] - Kain Technology announced the departure of a core technical personnel, impacting its research capabilities [31] - ST Renfu received approval for clinical trials of a new drug for idiopathic pulmonary fibrosis [32] Group 11 - Sanbo Brain Science's established brain science fund has completed registration with the Asset Management Association of China [33] - Tongyou Technology plans to apply for a 70 million yuan credit line from Beijing Bank, using its property as collateral [34] - Bai Ao Intelligent signed a significant equipment sales contract worth approximately 27.5021 million yuan [35] Group 12 - ST Xinyan received all restructuring investment funds totaling 2.239 billion yuan, entering the execution phase of its restructuring plan [36] - Dalu Real Estate's subsidiary decided to terminate a planned acquisition of a 60% stake in Beijing Chengzhu Real Estate [38] - Huiyu Pharmaceutical's products received marketing approval in Italy and Norway [39]
*ST新研(300159.SZ):收到重整投资人全部重整投资款
Ge Long Hui A P P· 2025-12-19 07:59
格隆汇12月19日丨*ST新研(300159.SZ)公布,截至2025年12月18日,管理人账户已收到全体投资人支付 的全部重整投资款,合计金额2,239,117,683.60元。本次所有重整投资人已经全部足额支付重整投资款。 ...
*ST新研:收到重整投资人全部重整投资款22.39亿元
Xin Lang Cai Jing· 2025-12-19 07:49
*ST新研公告,公司于2025年12月18日晚收到重整管理人通知,管理人账户已收到全体重整投资人支付 的全部重整投资款,合计金额22.39亿元。此前,公司在预重整期间与产业投资人及财务投资人签署了 重整投资协议,重整投资人应当支付的全部重整投资款合计金额为22.39亿元。 ...
*ST新研(300159) - 关于收到重整投资人全部重整投资款的公告
2025-12-19 07:40
1、法院已裁定批准重整计划,公司和子公司重整计划进入执行阶段,在重 整计划执行期间,如公司不能执行或者不执行重整计划将被宣告破产。如果公司 被宣告破产,公司将进入破产清算程序,根据《深圳证券交易所创业板股票上市 规则》第10.4.18条的规定,公司股票将面临被终止上市的风险。 新疆机械研究院股份有限公司 关于收到重整投资人全部重整投资款的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 新疆机械研究院股份有限公司(以下简称"公司")于2025年12月18日晚, 收到公司重整管理人的通知,管理人账户已收到全体重整投资人支付的全部重整 投资款,现将相关情况公告如下: 一、重整投资协议签署情况 公司在预重整期间分别与产业投资人及财务投资人签署了重整投资协议。前 述重整投资人应当支付的全部重整投资款合计金额人民币2,239,117,683.60元。 二、重整投资款的支付情况 截至2025年12月18日,管理人账户已收到全体投资人支付的全部重整投资 款,合计金额2,239,117,683.60元。本次所有重整投资人已经全部足额支付重整 投资款。 三、风险提示 证券代 ...
*ST新研(300159)披露关于重整计划资本公积金转增股本事项实施的公告,12月18日股价下跌0.31%

Sou Hu Cai Jing· 2025-12-18 14:33
Group 1 - The stock price of *ST Xin Yan (300159) closed at 3.21 yuan on December 18, 2025, down 0.31% from the previous trading day, with a total market capitalization of 4.801 billion yuan [1] - The company announced a capital reserve increase, converting 1,794,775,108 shares based on a total share capital of 1,495,645,923 shares, resulting in a new total share capital of 3,290,421,031 shares [1] - The share increase will not be distributed to existing shareholders, with 360 million shares allocated for debt repayment and 1,434,775,108 shares for introducing restructuring investors [1] Group 2 - The record date for the share increase is December 23, 2025, and the shares will be listed on December 24, 2025 [1] - The company's stock will be suspended for one day on December 23, 2025, and will resume trading on December 24, 2025 [1]
*ST新研(300159) - 关于重整计划资本公积金转增股本事项实施的公告
2025-12-18 10:54
新疆机械研究院股份有限公司 关于重整计划资本公积金转增股本事项实施的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误 导性陈述或重大遗漏。 特别提示: 1、根据乌鲁木齐市中级人民法院(以下简称"乌鲁木齐中院")于 2025 年 12 月 16 日裁定批准的《新疆机械研究院股份有限公司重整计划》(以下简称 "《重整计划》"),新疆机械研究院股份有限公司(以下简称"新研股份"或 "公司")以新研股份现有总股本 1,495,645,923 股为基数,按照每 10 股转增 12 股的比例实施资本公积金转增股本,共计转增 1,794,775,108 股股票,转增完成 后,新研股份总股本将由 1,495,645,923 股增加至 3,290,421,031 股(最终转增股 票准确数量以中国证券登记结算有限责任公司深圳分公司实际登记确认的数量 为准)。前述转增形成的 1,794,775,108 股股票不向原股东分配,其中 360,000,000 股股票清偿新研股份及子公司四川新航钛科技有限公司(以下简称"四川新航钛") 的债务,1,434,775,108 股股票用于引入重整投资人。 2、由于 ...
*ST新研(300159) - 关于资本公积金转增股本实施后首个交易日开盘参考价调整事项的风险提示公告
2025-12-18 10:54
证券代码:300159 证券简称:*ST 新研 公告编号:2025-074 新疆机械研究院股份有限公司 关于资本公积金转增股本实施后首个交易日开盘参考价调 整事项的风险提示公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假 记载、误导性陈述或重大遗漏。 特别提示: 由于本次资本公积金转增股本系重整程序中出资人权益调整的一部分,与一 般情形下的上市公司资本公积转增股本存在明显差异,公司根据《深圳证券交易 所交易规则》(2023 年修订)(以下简称《交易规则》)第 4.4.2 条的相关规定, 结合本次重整资本公积金转增股本的实际情况,调整除权参考价格计算公式。如 果股权登记日公司股票收盘价高于本次重整新研股份资本公积金转增股本的平 均价 2.45 元/股,公司股票按照前述拟调整后的除权(息)参考价于股权登记日 次一交易日调整开盘参考价,股权登记日次一交易日证券买卖,按上述开盘参考 价格作为计算涨跌幅度的基准;如果股权登记日公司股票收盘价低于或等于本次 重整新研股份资本公积金转增股本的平均价 2.45 元/股,公司股权登记日次一交 易日的股票开盘参考价无需调整。根据重整计划,结合公司初步测算 ...